Journal Article

JAAD Game Changer: “High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa”

Journal of the American Academy of Dermatology (2024) 90(1) 90
DOI: 10.1016/j.jaad.2023.08.014
0Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Patterson, A. (2024). JAAD Game Changer: “High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa.” Journal of the American Academy of Dermatology, 90(1), 90. https://doi.org/10.1016/j.jaad.2023.08.014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free